IL-18 component offers hope for Macular Degeneration

041514

The online journal, Science of Translational Medicine, details the breakthrough discovery of a component of the immune system known as IL-18 that may hold the key to treating macular degeneration. Researchers at Trinity College in Dublin discovered that IL-18 acts as a “guardian of eyesight” by suppressing the production of damaging blood vessels behind the […]

Anti-VEGF eye injections could be replaced by eyedrops

031114

Patients suffering from the wet form of macular degeneration may soon be able to say goodbye to unpleasant injections and hello to eye drops as treatment for the disease. Recent research points to eye drops that are safe and effective in treating wet macular degeneration. Anti-VEGF injections are the current method of treatment because the […]

Anti-VEGF Therapy Reducing Severe Vision Loss in AMD

020614

Only introduced as a treatment for wet macular degeneration ten short years ago, Anti-VEGF injections are making a positive difference in the number of Americans going blind and moving to nursing homes. The wet form of macular degeneration advances more quickly than the dry form and previous treatments were not very effective in stopping the […]

Revolutionary 3-D retinal imaging technology developed by MIT

eye

A revolutionary hand-held scanner developed by researchers at MIT scans the entire retina in just seconds using 3-D imaging technology. The practical, hand-held scanner will enable even primary care providers to detect a number of blinding eye diseases such as macular degeneration, and glaucoma in their earliest stages. Using 3-D imaging and movement-correction, this new […]

Home monitoring device beneficial for wet AMD patients

Foresee

Patients who suffer from the advanced form of age-related macular degeneration benefit from utilizing the ForeseeHome monitoring device to help preserve their visual acuity. The National Eye Institute led the AREDS2 HOME Study to determine the value of using the ForeseeHome monitoring device compared with standard care alone for the detection of the progression of […]

Possible topical treatment being tested for macular degeneration

topical

A study conducted at Tufts University School of Medicine was recently published in PLOS ONE and details the findings of the research team’s successful use of a topical compound that inhibits the symptoms associated with dry and wet macular degeneration. Researchers used a compound called PPADS in its topical form. PPADS words by preventing the […]

Researchers identify two genes that increase risk of AMD

genes

Utilizing a new genetic mapping technique, researchers at the University of Michigan discovered two connecting genes that raise the risk of macular degeneration when they are defective. The new method of mapping genes uses ancestry-matched controls from existing gene databases which is something that had not been done before. Researchers examined 2,335 cases and 789 […]

New treatment on the horizon for wet AMD

wetamd

A new therapy that is being developed by researchers at the University of North Carolina School of Medicine is an invitreal injection that inhibits the class of proteins known as MDM2. Researchers are hopeful that this new therapy will provide a more effective alternative to anti-VEGF therapies that are presently the best available treatment for […]

New drug in development shown to be effective in treating AMD

lab

Patients who suffer from the wet form of age-related macular degeneration have encouraging news from Roche, the manufacturer of lampalizumab. Phase II study results show that the drug slowed the progression of macular degeneration. Researchers noted a 20.4% reduction in the geographic atrophy of patients after being treated on a monthly basis. Roche conducted a […]

Eylea injections effective when other treatments for wet AMD have failed

eylea

A recent study conducted at the University of Iowa revealed that macular degeneration patients benefited from bimonthly injections of Eylea when monthly injections of Avastin or Lucentis failed. The injections are used for patients dealing with the wet form of macular degneration. Thirty-one patients in the study saw a reduction in fluid within their eyes […]